巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    22nd Century Group

    XXII
    1.800
    0.030
    1.69%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・22nd Century Group - 延遲價格・最後更新於 20/05 12:15
    最高位
    1.800
    最低位
    1.700
    開市價
    --
    前收市價
    1.770
    成交量(千)
    50.94
    成交額(百萬)
    0.65
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    296.17
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    5.250 - 1.420
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    22nd Century Group
    證券代碼
    XXII.US
    所屬板塊
    Drug Manufacturers - Specialty & Generic
    公司業務
    22nd Century Group Inc is a US-based plant biotechnology company. It focuses on developing technology that allows the increase or decrease in the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. The company is engaged in the research and development of potentially less harmful or modified risk tobacco products and novel tobacco plant varieties. Other business activities of the company include manufacture, marketing, sales, and distribution of SPECTRUM and VLN proprietary cigarettes, contract manufacturing of third-party branded tobacco products, research and development of plant varieties of hemp/cannabis, the sale of branded proprietary tobaccos, and among others.
    發行量
    162938375
    公司總部
    500 Seneca Street, Suite 507
    公司網址
    https://www.xxiicentury.com
    公司電郵
    mkuo@xxiicentury.com
    公司電話
    +1 716 270-1523
    暫無內容

    關於

    22nd Century Group(XXII.US)所屬的行業板塊為Drug Manufacturers - Specialty & Generic。
    22nd Century Group Inc is a US-based plant biotechnology company. It focuses on developing technology that allows the increase or decrease in the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. The company is engaged in the research and development of potentially less harmful or modified risk tobacco products and novel tobacco plant varieties. Other business activities of the company include manufacture, marketing, sales, and distribution of SPECTRUM and VLN proprietary cigarettes, contract manufacturing of third-party branded tobacco products, research and development of plant varieties of hemp/cannabis, the sale of branded proprietary tobaccos, and among others.
    詳細公司背景可參考: https://www.xxiicentury.com